{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T14:12:00Z","timestamp":1782310320856,"version":"3.54.5"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["Project Number. 625862; Tumorlymphainhibit"],"award-info":[{"award-number":["Project Number. 625862; Tumorlymphainhibit"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006673","name":"Fonds L\u00e9on Fredericq","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006673","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","award":["PDR T.0059.15"],"award-info":[{"award-number":["PDR T.0059.15"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Action de Recherche Concert\u00e9e (ARC) (Universit\u00e9 de Li\u00e8ge)","award":["ARC11\/16-02"],"award-info":[{"award-number":["ARC11\/16-02"]}]},{"name":"Televie","award":["7.4650.14"],"award-info":[{"award-number":["7.4650.14"]}]},{"DOI":"10.13039\/501100003033","name":"Ministerio de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n Productiva","doi-asserted-by":"publisher","award":["BIO2014-56092-R"],"award-info":[{"award-number":["BIO2014-56092-R"]}],"id":[{"id":"10.13039\/501100003033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002878","name":"Consejer\u00eda de Econom\u00eda, Innovaci\u00f3n, Ciencia y Empleo, Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["P12-CTS-1507 (Andalusian Government and FEDER)."],"award-info":[{"award-number":["P12-CTS-1507 (Andalusian Government and FEDER)."]}],"id":[{"id":"10.13039\/501100002878","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Centre Anticanc\u00e9reux pr\u00e8s l'Universit\u00e9 de Li\u00e8ge"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematol Oncol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13045-017-0484-1","type":"journal-article","created":{"date-parts":[[2017,6,19]],"date-time":"2017-06-19T08:36:35Z","timestamp":1497861395000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Targeting VEGFR-3\/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases"],"prefix":"10.1186","volume":"10","author":[{"given":"Melissa","family":"Garc\u00eda-Caballero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Paupert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Blacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen","family":"Van de Velde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Rodr\u00edguez","family":"Quesada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Angel","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"No\u00ebl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,19]]},"reference":[{"issue":"8","key":"484_CR1","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s12094-015-1460-2","volume":"18","author":"R Ramos-Medina","year":"2016","unstructured":"Ramos-Medina R, Moreno F, Lopez-Tarruella S, Lopez-Tarruella S, Del Monte-Mill\u00e1n M, M\u00e1rquez-Rodas I, Dur\u00e1n E, Jerez Y, Garcia-Saenz JA, Oca\u00f1a I, Andr\u00e9s S, et al. Review: circulating tumor cells in the practice of breast cancer oncology. Clin Transl Oncol. 2016;18(8):749\u201359.","journal-title":"Clin Transl Oncol"},{"issue":"5","key":"484_CR2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s13402-016-0281-9","volume":"39","author":"R Paduch","year":"2016","unstructured":"Paduch R. The role of lymphangiogenesis and angiogenesis in tumor metastasis. Cell Oncol. 2016;39(5):397\u2013410.","journal-title":"Cell Oncol"},{"issue":"Suppl 1","key":"484_CR3","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/S1743-9191(13)60022-9","volume":"11","author":"F Rovera","year":"2013","unstructured":"Rovera F, Fachinetti A, Rausei S, Chiappa C, Lavazza M, Arlant V, Marelli M, Boni L, Dionigi G, Dionigi R. Prognostic role of micrometastases in sentinel lymph node in patients with invasive breast cancer. Int J Surg. 2013;11 Suppl 1:S73\u201378.","journal-title":"Int J Surg"},{"issue":"9","key":"484_CR4","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1096\/fj.01-0945rev","volume":"16","author":"SA Stacker","year":"2002","unstructured":"Stacker SA, Baldwin ME, Achen MG. The role of tumor lymphangiogenesis in metastatic spread. FASEB J. 2002;16(9):922\u201334.","journal-title":"FASEB J"},{"issue":"11","key":"484_CR5","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/nm.2545","volume":"17","author":"K Alitalo","year":"2011","unstructured":"Alitalo K. The lymphatic vasculature in disease. Nat Med. 2011;17(11):1371\u201380.","journal-title":"Nat Med"},{"issue":"3","key":"484_CR6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nrc3677","volume":"14","author":"SA Stacker","year":"2014","unstructured":"Stacker SA, Williams SP, Karnezis T, Shayan R, Fox SB, Achen MG. Lymphangiogenesis and lymphatic vessel remodelling in cancer. Nat Rev Cancer. 2014;14(3):159\u201372.","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"484_CR7","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.crad.2015.04.019","volume":"70","author":"B Saffar","year":"2015","unstructured":"Saffar B, Bennett M, Metcalf C, Burrows S. Retrospective preoperative assessment of the axillary lymph nodes in patients with breast cancer and literature review. Clin Radiol. 2015;70(9):954\u20139.","journal-title":"Clin Radiol"},{"issue":"Pt B","key":"484_CR8","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.addr.2015.12.011","volume":"99","author":"LC Dieterich","year":"2016","unstructured":"Dieterich LC, Detmar M. Tumor lymphangiogenesis and new drug development. Adv Drug Deliv Rev. 2016;99(Pt B):148\u201360.","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"484_CR9","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.pathophys.2009.11.003","volume":"17","author":"S Ran","year":"2010","unstructured":"Ran S, Volk L, Hall K, Flister MG. Lymphangiogenesis and lymphatic metastasis in breast cancer. Pathophysiology. 2010;17(4):229\u201351.","journal-title":"Pathophysiology"},{"issue":"11","key":"484_CR10","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00109-015-1351-6","volume":"93","author":"JP Sleeman","year":"2015","unstructured":"Sleeman JP. The lymph node pre-metastatic niche. J Mol Med. 2015;93(11):1173\u201384.","journal-title":"J Mol Med"},{"issue":"Suppl 3","key":"484_CR11","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/S0960-9776(11)70295-8","volume":"20","author":"RS Kerbel","year":"2011","unstructured":"Kerbel RS. Reappraising antiangiogenic therapy for breast cancer. Breast. 2011;20 Suppl 3:S56\u201360.","journal-title":"Breast"},{"issue":"Suppl","key":"484_CR12","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/01.cco.0000397416.67622.10","volume":"23","author":"M Martin","year":"2011","unstructured":"Martin M. Understanding the value of antiangiogenic therapy in metastatic breast cancer. Curr Opin Oncol. 2011;23(Suppl):S1.","journal-title":"Curr Opin Oncol"},{"issue":"3","key":"484_CR13","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ccr.2009.01.027","volume":"15","author":"M Paez-Ribes","year":"2009","unstructured":"Paez-Ribes M, Allen E, Hudock J, Takeda T, Okuyama H, Vi\u00f1als F, Inoue M, Bergers G, Hanahan D, Casanovas O. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell. 2009;15(3):220\u201331.","journal-title":"Cancer Cell"},{"issue":"1","key":"484_CR14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.leukres.2010.07.038","volume":"35","author":"D Ribatti","year":"2011","unstructured":"Ribatti D. Antiangiogenic therapy accelerates tumour metastasis. Leuk Res. 2011;35(1):24\u20136.","journal-title":"Leuk Res"},{"issue":"4","key":"484_CR15","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00280-016-3134-3","volume":"78","author":"MW Saif","year":"2016","unstructured":"Saif MW, Knost JA, Chiorean EG, Kambhampati SR, Yu D, Pytowski B, Qin A, Kauh JS, O\u2019Neil BH. Phase 1 study of the anti-vascular endothelial growth factor receptor 3 monoclonal antibody LY3022856\/IMC-3C5 in patients with advanced and refractory solid tumors and advanced colorectal cancer. Cancer Chemother Pharmacol. 2016;78(4):815\u201324.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"484_CR16","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3390\/md12010279","volume":"12","author":"M Garc\u00eda-Caballero","year":"2014","unstructured":"Garc\u00eda-Caballero M, Ca\u00f1edo L, Fern\u00e1ndez-Medarde A, Medina MA, Quesada AR. The marine fungal metabolite, AD0157, inhibits angiogenesis by targeting the Akt signaling pathway. Mar Drugs. 2014;12(1):279\u201399.","journal-title":"Mar Drugs"},{"issue":"2","key":"484_CR17","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.cmet.2014.05.022","volume":"20","author":"NE Sounni","year":"2014","unstructured":"Sounni NE, Cimino J, Blacher S, Primac I, Truong A, Mazzucchelli G, Paye A, Calligaris D, Debois D, De Tulllio P, et al. Blocking lipid synthesis overcomes tumor regrowth and metastasis after antiangiogenic therapy withdrawal. Cell Metab. 2014;20(2):280\u201394.","journal-title":"Cell Metab"},{"issue":"5","key":"484_CR18","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1167\/iovs.12-10856","volume":"54","author":"B Detry","year":"2013","unstructured":"Detry B, Blacher S, Erpicum C, Paupert J, Maertens L, Maillard C, Munaut C, Sounni NE, Lambert V, Foidart JM, et al. Sunitinib inhibits inflammatory corneal lymphangiogenesis. Invest Ophthalmol Vis Sci. 2013;54(5):3082\u201393.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"484_CR19","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.exer.2009.02.021","volume":"89","author":"S Blacher","year":"2009","unstructured":"Blacher S, Detry B, Bruy\u00e8re F, Foidart JM, No\u00ebl A. Additional parameters for the morphometry of angiogenesis and lymphangiogenesis in corneal flat mounts. Exp Eye Res. 2009;89(2):274\u201376.","journal-title":"Exp Eye Res"},{"issue":"12","key":"484_CR20","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1111\/bph.13488","volume":"173","author":"M Garc\u00eda-Caballero","year":"2016","unstructured":"Garc\u00eda-Caballero M, Blacher S, Paupert J, Quesada AR, Medina MA, No\u00ebl A. Novel application assigned to toluquinol: inhibition of lymphangiogenesis by interfering with VEGF-C\/VEGFR-3 signaling pathway. Br J Pharmacol. 2016;173(12):1966\u201387.","journal-title":"Br J Pharmacol"},{"issue":"5","key":"484_CR21","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nmeth.1205","volume":"5","author":"F Bruy\u00e8re","year":"2008","unstructured":"Bruy\u00e8re F, Melen-Lamalle L, Blacher S, Roland G, Thiry M, Moons L, Frankenne F, Carmeliet P, Alitalo K, Libert C, et al. Modeling lymphangiogenesis in a three-dimensional culture system. Nat Methods. 2008;5(5):431\u201337.","journal-title":"Nat Methods"},{"issue":"6","key":"484_CR22","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/micc.12132","volume":"21","author":"RS Sweat","year":"2014","unstructured":"Sweat RS, Sloas DC, Murfee WL. VEGF-C induces lymphangiogenesis and angiogenesis in the rat mesentery culture model. Microcirculation. 2014;21(6):532\u201340.","journal-title":"Microcirculation"},{"issue":"21","key":"484_CR23","doi-asserted-by":"crossref","first-page":"5048","DOI":"10.1182\/blood-2011-12-400267","volume":"119","author":"B Detry","year":"2012","unstructured":"Detry B, Erpicum C, Paupert J, Blacher S, Maillard C, Bruy\u00e8re F, Pendeville H, Remacle T, Lambert V, Balsat C, et al. Matrix metalloproteinase-2 governs lymphatic vessel formation as an interstitial collagenase. Blood. 2012;119(21):5048\u201356.","journal-title":"Blood"},{"issue":"5","key":"484_CR24","doi-asserted-by":"crossref","first-page":"e97019","DOI":"10.1371\/journal.pone.0097019","volume":"9","author":"S Blacher","year":"2014","unstructured":"Blacher S, Erpicum C, Lenoir B, Paupert J, Moraes G, Ormenese S, Bullinger E, Noel A. Cell invasion in the spheroid sprouting assay: a spatial organisation analysis adaptable to cell behaviour. PLoS One. 2014;9(5):e97019.","journal-title":"PLoS One"},{"issue":"Pt B","key":"484_CR25","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.addr.2016.01.020","volume":"99","author":"Y Yoshimatsu","year":"2016","unstructured":"Yoshimatsu Y, Miyazaki H, Watabe T. Roles of signaling and transcriptional networks in pathological lymphangiogenesis. Adv Drug Deliv Rev. 2016;99(Pt B):161\u201371.","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"484_CR26","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/84643","volume":"7","author":"M Skobe","year":"2001","unstructured":"Skobe M, Hawighorst T, Jackson DG, Prevo R, Janes L, Velasco P, Riccardi L, Alitalo K, Claffey K, Detmar M. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med. 2001;7(2):192\u20138.","journal-title":"Nat Med"},{"issue":"4","key":"484_CR27","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/emboj\/20.4.672","volume":"20","author":"SJ Mandriota","year":"2001","unstructured":"Mandriota SJ, Jussila L, Jeltsch M, Compagni A, Baetens D, Prevo R, Banerji S, Huarte J, Montesano R, Jackson DG, et al. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumor metastasis. EMBO J. 2001;20(4):672\u201382.","journal-title":"EMBO J"},{"issue":"5","key":"484_CR28","first-page":"1786","volume":"61","author":"T Karpanen","year":"2001","unstructured":"Karpanen T, Egeblad M, Karkkainen MJ, Kubo H, Yl\u00e4-Herttuala S, J\u00e4\u00e4ttel\u00e4 M, Alitalo K. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res. 2001;61(5):1786\u201390.","journal-title":"Cancer Res"},{"issue":"8","key":"484_CR29","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/sj.bjc.6603067","volume":"94","author":"AV Timoshenko","year":"2006","unstructured":"Timoshenko AV, Chakraborty C, Wagner GF, Lala PK. COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer. Br J Cancer. 2006;94(8):1154\u201363.","journal-title":"Br J Cancer"},{"issue":"7","key":"484_CR30","doi-asserted-by":"crossref","first-page":"e41171","DOI":"10.1371\/journal.pone.0041171","volume":"7","author":"I Tekedereli","year":"2012","unstructured":"Tekedereli I, Alpay SN, Tavares CD, Cobanoglu ZE, Kaoud TS, Sahin I, Sood AK, Lopez-Berestein G, Dalby KN, Ozpolat B. Targeted silencing of elongation factor 2 kinase suppresses growth and sensitizes tumors to doxorubicin in an orthotopic model of breast cancer. PLoS One. 2012;7(7):e41171.","journal-title":"PLoS One"},{"issue":"4","key":"484_CR31","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.bbrc.2013.12.064","volume":"443","author":"P Cheng","year":"2014","unstructured":"Cheng P, Dai W, Wang F, Lu J, Shen M, Chen K, Li J, Zhang Y, Wang C, Yang J, et al. Ethyl pyruvate inhibits proliferation and induces apoptosis of hepatocellular carcinoma via regulation of the HMGB1-RAGE and AKT pathways. Biochem Biophys Res Commun. 2014;443(4):1162\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"484_CR32","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/jnci\/94.11.819","volume":"94","author":"Y He","year":"2002","unstructured":"He Y, Kozaki K, Karpanen T, Koshikawa K, Yla-Herttuala S, Takahashi T, Alitalo K. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. J Natl Cancer Inst. 2002;94(11):819\u201325.","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"484_CR33","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1158\/0008-5472.CAN-05-1843","volume":"66","author":"N Roberts","year":"2006","unstructured":"Roberts N, Kloos B, Cassella M, Podgrabinska S, Persaud K, Wu Y, Pytowski B, Skobe M. Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2. Cancer Res. 2006;66(5):2650\u20137.","journal-title":"Cancer Res"},{"issue":"17","key":"484_CR34","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.1158\/1078-0432.CCR-07-5270","volume":"14","author":"J Matsui","year":"2008","unstructured":"Matsui J, Funahashi Y, Uenaka T, Watanabe T, Tsuruoka A, Asada M. Multi-kinase inhibitor E7080 suppresses lymph node and lung metastases of human mammary breast tumor MDA-MB-231 via inhibition of vascular endothelial growth factor-receptor (VEGF-R) 2 and VEGF-R3 kinase. Clin Cancer Res. 2008;14(17):5459\u201365.","journal-title":"Clin Cancer Res"},{"issue":"12","key":"484_CR35","doi-asserted-by":"crossref","first-page":"4754","DOI":"10.1158\/0008-5472.CAN-07-5809","volume":"68","author":"CA Heckman","year":"2008","unstructured":"Heckman CA, Holopainen T, Wirzenius M, Keskitalo S, Jeltsch M, Yl\u00e4-Herttuala S, Wedge SR, J\u00fcrgensmeier JM, Alitalo K. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis. Cancer Res. 2008;68(12):4754\u201362.","journal-title":"Cancer Res"},{"issue":"1","key":"484_CR36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1158\/1535-7163.MCT-08-0679","volume":"8","author":"T Schomber","year":"2009","unstructured":"Schomber T, Zumsteg A, Strittmatter K, Crnic I, Antoniadis H, Littlewood-Evans A, Wood J, Christofori G. Differential effects of the vascular endothelial growth factor receptor inhibitor PTK787\/ZK222584 on tumor angiogenesis and tumor lymphangiogenesis. Mol Cancer Ther. 2009;8(1):55\u201363.","journal-title":"Mol Cancer Ther"},{"issue":"19","key":"484_CR37","doi-asserted-by":"crossref","first-page":"7828","DOI":"10.1158\/0008-5472.CAN-08-1488","volume":"68","author":"JB Burton","year":"2008","unstructured":"Burton JB, Priceman SJ, Sung JL, Brakenhielm E, An DS, Pytowski B, Alitalo K, Wu L. Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axis. Cancer Res. 2008;68(19):7828\u201337.","journal-title":"Cancer Res"},{"issue":"1","key":"484_CR38","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13045-016-0340-8","volume":"9","author":"J Yu","year":"2016","unstructured":"Yu J, Zhang Y, Leung LH, Liu L, Yang F, Yao X. Efficacy and safety of angiogenesis inhibitors in advanced gastric cancer: a systematic review and meta-analysis. J Hematol Oncol. 2016;9(1):111.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"484_CR39","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13045-016-0332-8","volume":"9","author":"Y Sun","year":"2016","unstructured":"Sun Y, Niu W, Du F, Du C, Li S, Wang J, Li L, Wang F, Hao Y, Li C, et al. Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors. J Hematol Oncol. 2016;9(1):105.","journal-title":"J Hematol Oncol"},{"key":"484_CR40","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1471-2407-12-107","volume":"12","author":"P Rutkowski","year":"2012","unstructured":"Rutkowski P, Bylina E, Klimczak A, Switaj T, Falkowski S, Kroc J, Lugowska I, Brzeskwiniewicz M, Melerowicz W, Osuch C, et al. The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure\u2014one institution study. BMC Cancer. 2012;12:107.","journal-title":"BMC Cancer"},{"issue":"9","key":"484_CR41","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJMc1616636","volume":"376","author":"S Zhang","year":"2017","unstructured":"Zhang S. Adjuvant sunitinib in renal-cell carcinoma. N Engl J Med. 2017;376(9):893.","journal-title":"N Engl J Med"},{"key":"484_CR42","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijsu.2017.01.045","volume":"39","author":"CN Yeh","year":"2017","unstructured":"Yeh CN, Wang SY, Tsai CY, Chen YY, Liu CT, Chiang KC, Chen TW, Liu YY, Yeh TS. Surgical management of patients with progressing metastatic gastrointestinal stromal tumors receiving sunitinib treatment: a prospective cohort study. Int J Surg. 2017;39:30\u20136.","journal-title":"Int J Surg"}],"container-title":["Journal of Hematology & Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-017-0484-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,18]],"date-time":"2018-05-18T11:30:05Z","timestamp":1526643005000},"score":1,"resource":{"primary":{"URL":"http:\/\/jhoonline.biomedcentral.com\/articles\/10.1186\/s13045-017-0484-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,19]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["484"],"URL":"https:\/\/doi.org\/10.1186\/s13045-017-0484-1","relation":{},"ISSN":["1756-8722"],"issn-type":[{"value":"1756-8722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,19]]},"article-number":"122"}}